Xcopri 12.5 mg (Cenobamate TABLET) 12.5 MG

XCOPRI 12.5 MG tablets contain cenobamate, an anticonvulsant used to manage certain types of seizures. This medication is prescribed to help control epileptic activity in adults.

Strength

12.5 MG

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XCOPRI 12.5 MG tablets are primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults. Cenobamate, the active ingredient, works by stabilizing electrical activity in the brain. This medication is often considered when other treatments have not been effective. Always consult a healthcare provider to determine if XCOPRI is suitable for your condition.

Side Effects

Common effects of XCOPRI 12.5 MG tablets may include dizziness, somnolence, and fatigue. Some users might experience gastrointestinal issues such as nausea or vomiting. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

XCOPRI 12.5 MG tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Avoid sudden discontinuation of the medication without consulting a healthcare professional. Store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

XCOPRI 12.5 MG tablets may interact with other medications, including those metabolized by the liver's cytochrome P450 enzymes. Alcohol and certain anticonvulsants can also affect the efficacy and safety of cenobamate. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

XCOPRI 12.5 MG tablets are used as an adjunctive therapy for the treatment of partial-onset seizures in adults.

XCOPRI 12.5 MG tablets are taken orally, typically once daily. Follow the dosage and administration instructions provided by your healthcare provider.

Common side effects may include dizziness, somnolence, fatigue, and gastrointestinal issues such as nausea or vomiting.

It is advisable to avoid alcohol while taking XCOPRI 12.5 MG tablets, as it may interact with the medication and affect its efficacy.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.